Literature DB >> 10385690

Preferential coassembly of alpha4 and delta subunits of the gamma-aminobutyric acidA receptor in rat thalamus.

C Sur1, S J Farrar, J Kerby, P J Whiting, J R Atack, R M McKernan.   

Abstract

Pharmacological study of rat thalamic gamma-aminobutyric acidA (GABAA) receptors revealed the presence of two distinct populations, namely, diazepam-sensitive and diazepam-insensitive [3H]Ro15-4513 binding sites accounting for 94 +/- 2% (1339 +/- 253 fmol/mg protein) and 6 +/- 2% (90 +/- 44 fmol/mg protein) of total sites, respectively. Thalamic diazepam-insensitive sites exhibited a pharmacology that was distinct from diazepam-sensitive sites but comparable to that of the alpha4beta3gamma2 subtype of the GABAA receptor stably expressed in L(tk-) cells. Immunoprecipitation experiments with a specific anti-alpha4-antiserum immunoprecipitated 20 and 7% of total thalamic [3H]muscimol and [3H]Ro15-4513 sites, respectively. Combinatorial immunoprecipitation using antisera against the alpha4, gamma2, and delta subunit revealed that alpha4delta- and alpha4gamma2-containing receptors account for 13 +/- 2 and 8 +/- 3% of [3H]muscimol sites from thalamus, respectively. It also indicated that all delta subunits coexist with an alpha4 subunit in this brain region. In conclusion, our results show that in rat thalamus both alpha4betagamma2 and alpha4betadelta subtypes are expressed but alpha4betadelta is the major alpha4-containing GABAA receptor population.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10385690     DOI: 10.1124/mol.56.1.110

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  91 in total

Review 1.  Distinguishing between GABA(A) receptors responsible for tonic and phasic conductances.

Authors:  I Mody
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

2.  Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors: commentary on Brown et al.

Authors:  J J Lambert; D Belelli
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

3.  Distinct activities of GABA agonists at synaptic- and extrasynaptic-type GABAA receptors.

Authors:  Martin Mortensen; Bjarke Ebert; Keith Wafford; Trevor G Smart
Journal:  J Physiol       Date:  2010-02-22       Impact factor: 5.182

4.  Changes in expression of GABAA alpha4 subunit mRNA in the brain under anesthesia induced by volatile and intravenous anesthetics.

Authors:  Shusuke Sekine; Shohei Matsumoto; Atsushi Issiki; Taiko Kitamura; Jinzo Yamada; Yasuo Watanabe
Journal:  Neurochem Res       Date:  2006-05-03       Impact factor: 3.996

Review 5.  Stress, ethanol, and neuroactive steroids.

Authors:  Giovanni Biggio; Alessandra Concas; Paolo Follesa; Enrico Sanna; Mariangela Serra
Journal:  Pharmacol Ther       Date:  2007-05-08       Impact factor: 12.310

Review 6.  Studies of ethanol actions on recombinant delta-containing gamma-aminobutyric acid type A receptors yield contradictory results.

Authors:  Cecilia M Borghese; R Adron Harris
Journal:  Alcohol       Date:  2007-05-23       Impact factor: 2.405

7.  Unanticipated structural and functional properties of delta-subunit-containing GABAA receptors.

Authors:  Kuldeep H Kaur; Roland Baur; Erwin Sigel
Journal:  J Biol Chem       Date:  2009-01-13       Impact factor: 5.157

8.  Reduced GABA(A) receptor-mediated tonic inhibition in aged rat auditory thalamus.

Authors:  Ben D Richardson; Lynne L Ling; Victor V Uteshev; Donald M Caspary
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

9.  Trace and contextual fear conditioning is enhanced in mice lacking the alpha4 subunit of the GABA(A) receptor.

Authors:  M D Moore; J Cushman; D Chandra; G E Homanics; R W Olsen; M S Fanselow
Journal:  Neurobiol Learn Mem       Date:  2009-12-14       Impact factor: 2.877

10.  Novel subunit-specific tonic GABA currents and differential effects of ethanol in the central amygdala of CRF receptor-1 reporter mice.

Authors:  Melissa A Herman; Candice Contet; Nicholas J Justice; Wylie Vale; Marisa Roberto
Journal:  J Neurosci       Date:  2013-02-20       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.